Devaux PF, Morris R. Transmembrane asymmetry and lateral domains in biological membranes. Traffic. 2004;5(4):241–6.
CAS
PubMed
Google Scholar
Gascard P, et al. Asymmetric distribution of phosphoinositides and phosphatidic acid in the human erythrocyte membrane. Biochim Biophys Acta. 1991;1069(1):27–36.
CAS
PubMed
Google Scholar
Wielders SJH, et al. Absence of platelet-dependent fibrin formation in a patient with Scott syndrome. Throm Haemost. 2009;102(07):76–82.
CAS
Google Scholar
Kawano M, Nagata S. Lupus-like autoimmune disease caused by a lack of Xkr8, a caspase-dependent phospholipid scramblase. Proc Natl Acad Sci. 2018;115(9):2132–7.
CAS
PubMed
PubMed Central
Google Scholar
Li J, et al. Inflammatory cytokines enhance procoagulant activity of platelets and endothelial cells through phosphatidylserine exposure in patients with essential hypertension. J Thromb Thrombolysis. 2020:1–8.
Croteau SE, et al. Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiency. J Thromb Haemost: JTH. 2021.
Neher JJ, et al. Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death. J Immunol. 2011;186(8):4973–83.
CAS
PubMed
Google Scholar
Yasen A, et al. HIV internalization into oral and genital epithelial cells by endocytosis and macropinocytosis leads to viral sequestration in the vesicles. Virology. 2018;515:92–107.
CAS
PubMed
Google Scholar
Rhein BA, et al. Characterization of human and murine T-cell immunoglobulin mucin domain 4 (TIM-4) IgV domain residues critical for Ebola virus entry. J Virol. 2016;90(13):6097–111.
CAS
PubMed
PubMed Central
Google Scholar
Bhattacharyya S, et al. Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host Microbe. 2013;14(2):136–47.
CAS
PubMed
PubMed Central
Google Scholar
Shimojima M, et al. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol. 2006;80(20):10109–16.
CAS
PubMed
PubMed Central
Google Scholar
Shimojima M, Ikeda Y, Kawaoka Y. The mechanism of Axl-mediated Ebola virus infection. J Infect Dis. 2007;196(Suppl 2):S259–63.
CAS
PubMed
Google Scholar
Chu L-W, et al. TIM-1 as a signal receptor triggers dengue virus-induced autophagy. Int J Mol Sci. 2019;20(19):4893.
CAS
PubMed Central
Google Scholar
Carnec X, et al. The phosphatidylserine and phosphatidylethanolamine receptor CD300a binds dengue virus and enhances infection. J Virol. 2016;90(1):92–102.
CAS
PubMed
Google Scholar
Meertens L, et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe. 2012;12(4):544–57.
CAS
PubMed
PubMed Central
Google Scholar
Shibata T, et al. Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma. J Immunol. 2014;192(8):3569–81.
CAS
PubMed
Google Scholar
Shibata T, et al. Respiratory syncytial virus infection exacerbates pneumococcal pneumonia via Gas6/Axl-mediated macrophage polarization. J Clin Invest. 2020;130(6):3021–37.
CAS
PubMed
PubMed Central
Google Scholar
Shibata T, Ato M. A critical role of Gas6/Axl signal in allergic airway responses during RSV vaccine-enhanced disease. Immunol Cell Biol. 2017;95(10):906–15.
CAS
PubMed
Google Scholar
Birge RB, et al. Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ. 2016;23(6):962–78.
CAS
PubMed
PubMed Central
Google Scholar
Yin Y, et al. Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation. Cancer Immunol Res. 2013;1(4):256–68.
CAS
PubMed
Google Scholar
Park M, Kang KW. Phosphatidylserine receptor-targeting therapies for the treatment of cancer. Arch Pharm Res. 2019;42(7):617–28.
CAS
PubMed
Google Scholar
Stanford JC, et al. Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution. J Clin Inv. 2014;124(11):4737–52.
CAS
Google Scholar
Argañaraz GA, da Fonseca Palmeira J, Argañaraz ER. Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19. Cell Commun Signal. 2020;18(1):1–10.
Google Scholar
Lind SE. Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation. Heliyon. 2021:e06033.
van der Meer JHM, van der Poll T, van ‘t Veer C. TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis. Blood, J Am Soc Hematol. 2014;123(16):2460–9.
Google Scholar
Verhamme P, Hoylaerts MF. Hemostasis and inflammation: two of a kind. Thromb J. 2009;7(1):1–3.
Google Scholar
Kim S-J, Davis RP, Jenne CN. Platelets as modulators of inflammation. Thieme Med Publishers. 2018.
Hoffman M. A cell-based model of coagulation and the role of factor VIIa. Blood Rev. 2003;17:S1–5.
PubMed
Google Scholar
Hoffman M, Monroe Iii DM. A cell-based model of hemostasis. Thromb Haemost. 2001;85(06):958–65.
CAS
PubMed
Google Scholar
Smith SA. The cell-based model of coagulation. J Vet Emerg Crit Care. 2009;19(1):3–10.
Google Scholar
Sucker C, Zotz RB. The cell-based coagulation model, in Perioperative hemostasis: Springer; 2015. p. 3–11.
Google Scholar
Stoilova-McPhie, S., Factor VIII and Factor V Membrane Bound Complexes, in Macromolecular Protein Complexes III: Structure and Function. 2021, Springer.153–175.
Cosemans J, et al. Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization. J Thromb Haemost. 2010;8(8):1797–808.
CAS
PubMed
Google Scholar
Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol. 2008;8(5):327–36.
CAS
PubMed
PubMed Central
Google Scholar
Freeman GJ, et al. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev. 2010;235(1):172–89.
CAS
PubMed
PubMed Central
Google Scholar
Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239–57.
CAS
PubMed
PubMed Central
Google Scholar
Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett. 2004;149(1–3):19–23.
CAS
PubMed
Google Scholar
Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104(4):487–501.
CAS
PubMed
Google Scholar
Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002;2(4):277–88.
CAS
PubMed
Google Scholar
Suzuki J, et al. Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells. Science. 2013;341(6144):403–6.
CAS
PubMed
Google Scholar
Segawa K, Kurata S, Nagata S. Human type IV P-type ATPases that work as plasma membrane phospholipid Flippases and their regulation by caspase and calcium. J Biol Chem. 2016;291(2):762–72.
CAS
PubMed
Google Scholar
Segawa K, et al. Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure. Science. 2014;344(6188):1164–8.
CAS
PubMed
Google Scholar
Suzuki J, Imanishi E, Nagata S. Xkr8 phospholipid scrambling complex in apoptotic phosphatidylserine exposure. Proc Natl Acad Sci. 2016;113(34):9509–14.
CAS
PubMed
PubMed Central
Google Scholar
Nagata S, et al. Exposure of phosphatidylserine on the cell surface. Cell Death Differ. 2016;23(6):952–61.
CAS
PubMed
PubMed Central
Google Scholar
Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol cell Biol. 2004;5(11):897–907.
CAS
PubMed
Google Scholar
Budihardjo I, et al. Biochemical pathways of caspase activation during apoptosis. Annual Rev Cell Dev Biol. 1999;15(1):269–90.
CAS
Google Scholar
Graham DK, et al. The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer. Nat Rev Cancer. 2014;14(12):769–85.
CAS
PubMed
Google Scholar
Das M, Zhu C, Kuchroo VK. Tim-3 and its role in regulating anti-tumor immunity. Immunol Rev. 2017;276(1):97–111.
CAS
PubMed
PubMed Central
Google Scholar
Kimani SG, et al. Contribution of defective PS recognition and Efferocytosis to chronic inflammation and autoimmunity. Front Immunol. 2014;5:566.
PubMed
PubMed Central
Google Scholar
Suzuki J, et al. Calcium-dependent phospholipid scrambling by TMEM16F. Nature. 2010;468(7325):834–8.
CAS
PubMed
Google Scholar
Bull LN, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet. 1998;18(3):219–24.
CAS
PubMed
Google Scholar
Onat OE, et al. Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion. Eur J Hum Genet. 2013;21(3):281–5.
PubMed
Google Scholar
Siggs OM, et al. The P4-type ATPase ATP11C is essential for B lymphopoiesis in adult bone marrow. Nat Immun. 2011;12(5):434–40.
CAS
Google Scholar
Yabas M, et al. ATP11C is critical for the internalization of phosphatidylserine and differentiation of B lymphocytes. Nat Immun. 2011;12(5):441–9.
CAS
Google Scholar
Andersen JP, et al. P4-ATPases as phospholipid flippases—structure, function, and enigmas. Front Physiol. 2016;7:275.
PubMed
PubMed Central
Google Scholar
Nagata S, Sakuragi T, Segawa K. Flippase and scramblase for phosphatidylserine exposure. Curr Opin Immunol. 2020;62:31–8.
CAS
PubMed
Google Scholar
Kansal S, et al. Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis. J Antimicrob Chemother. 2012;67(11):2650–60.
CAS
PubMed
Google Scholar
Brouckaert G, et al. Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol Biol Cell. 2004;15(3):1089–100.
CAS
PubMed
PubMed Central
Google Scholar
Hiraizumi M, et al. Cryo-EM structures capture the transport cycle of the P4-ATPase flippase. Science. 2019;365(6458):1149–55.
CAS
PubMed
Google Scholar
Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol. 2020;21(6):605–14.
CAS
PubMed
PubMed Central
Google Scholar
Fadok VA, et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148(7):2207–16.
CAS
PubMed
Google Scholar
Gardai SJ, et al. Recognition ligands on apoptotic cells: a perspective. J leukocyte Biol. 2006;79(5):896–903.
CAS
PubMed
Google Scholar
Kaminska A, Enguita FJ, Stepien EL. Lactadherin: an unappreciated haemostasis regulator and potential therapeutic agent. Vascul Pharmacol. 2018;101:21–8.
CAS
PubMed
Google Scholar
Hanayama R, et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 2004;304(5674):1147–50.
CAS
PubMed
Google Scholar
Simhadri VR, et al. Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells. Blood, J Am Soc Hematol. 2012;119(12):2799–809.
CAS
Google Scholar
Park D, et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature. 2007;450(7168):430–4.
CAS
PubMed
Google Scholar
Park S-Y, et al. Epidermal growth factor-like domain repeat of stabilin-2 recognizes phosphatidylserine during cell corpse clearance. Mol Cell Biol. 2008;28(17):5288–98.
CAS
PubMed
PubMed Central
Google Scholar
Park S-Y, Kim I-S. Stabilin receptors: role as phosphatidylserine receptors. Biomolecules. 2019;9(8):387.
CAS
PubMed Central
Google Scholar
He M, et al. Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep. 2011;12(4):358–64.
CAS
PubMed
PubMed Central
Google Scholar
Murphy JE, et al. LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells. Biochem J. 2006;393(1):107–15.
CAS
PubMed
Google Scholar
Lemke G. Biology of the TAM receptors. Cold Spring Harb Perspect Biol. 2013;5(11):a009076.
PubMed
PubMed Central
Google Scholar
Hubbard SR, Till JH. Protein tyrosine kinase structure and function. Annual Rev Biochem. 2000;69(1):373–98.
CAS
Google Scholar
Zwick E, Bange J, Ullrich A. Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocrine-related Cancer. 2001;8(3):161–73.
CAS
PubMed
Google Scholar
Seitz HM, et al. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. J Immunol. 2007;178(9):5635–42.
CAS
PubMed
Google Scholar
Rothlin CV, et al. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell. 2007;131(6):1124–36.
CAS
PubMed
Google Scholar
Caraux A, et al. Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases. Nat Immunol. 2006;7(7):747–54.
CAS
PubMed
Google Scholar
Prieto AL, Weber JL, Lai C. Expression of the receptor protein-tyrosine kinases Tyro-3, Axl, and Mer in the developing rat central nervous system. J Comp Neurol. 2000;425(2):295–314.
CAS
PubMed
Google Scholar
Prasad D, et al. TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci. 2006;33(1):96–108.
CAS
PubMed
Google Scholar
Wang H, et al. Immunoexpression of tyro 3 family receptors—tyro 3, Axl, and Mer—and their ligand Gas6 in postnatal developing mouse testis. J Histochem Cytochem. 2005;53(11):1355–64.
CAS
PubMed
Google Scholar
Lee C-H, Chun T. Anti-inflammatory role of TAM family of receptor tyrosine kinases via modulating macrophage function. Mol Cells. 2019;42(1):1.
PubMed
PubMed Central
Google Scholar
Angelillo-Scherrer A, et al. Role of Gas6 in erythropoiesis and anemia in mice. J Clin Invest. 2008;118(2):583–96.
CAS
PubMed
PubMed Central
Google Scholar
Stitt TN, et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the tyro 3/Axl family of receptor tyrosine kinases. Cell. 1995;80(4):661–70.
CAS
PubMed
Google Scholar
Mark MR, et al. Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl. J Biol Chem. 1996;271(16):9785–9.
CAS
PubMed
Google Scholar
Lew ED, et al. Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities. Elife. 2014;3:e03385.
PubMed Central
Google Scholar
Wu Y, et al. A role for Mer tyrosine kinase in αvβ5 integrin-mediated phagocytosis of apoptotic cells. J Cell Sci. 2005;118(3):539–53.
CAS
PubMed
Google Scholar
Wu Y, Tibrewal N, Birge RB. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol. 2006;16(4):189–97.
CAS
PubMed
Google Scholar
Castellano F, Montcourrier P, Chavrier P. Membrane recruitment of Rac1 triggers phagocytosis. J Cell Sci. 2000;113(17):2955–61.
CAS
PubMed
Google Scholar
Cvetanovic M, Ucker DS. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J Immunol. 2004;172(2):880–9.
CAS
PubMed
Google Scholar
Deng T, et al. Toll-like receptor-mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages. Immunology. 2012;135(1):40–50.
CAS
PubMed
PubMed Central
Google Scholar
Tibrewal N, et al. Autophosphorylation docking site Tyr-867 in Mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipopolysaccharide-inducible NF-κB transcriptional activation. J Biol Chem. 2008;283(6):3618–27.
CAS
PubMed
Google Scholar
Tourdot BE, et al. Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1. Biochemistry. 2013;52(15):2597–608.
CAS
PubMed
Google Scholar
Graham DK, et al. Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth Differ: Mol Biol J Am Assoc Cancer Res. 1994;5(6):647–57.
CAS
Google Scholar
O'Bryan JP, et al. Axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol. 1991;11(10):5016–31.
CAS
PubMed
PubMed Central
Google Scholar
Lai C, Gore M, Lemke G. Structure, expression, and activity of tyro 3, a neural adhesion-related receptor tyrosine kinase. Oncogene. 1994;9(9):2567–78.
CAS
PubMed
Google Scholar
Nagata K, et al. Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, sky, and Mer receptor tyrosine kinases. J Biol Chem. 1996;271(47):30022–7.
CAS
PubMed
Google Scholar
Hafizi S, Dahlbäck B. Gas6 and protein S. FEBS J. 2006;273(23):5231–44.
CAS
PubMed
Google Scholar
Segawa K, Nagata S. An apoptotic ‘eat me’signal: phosphatidylserine exposure. Trends Cell Biol. 2015;25(11):639–50.
CAS
PubMed
Google Scholar
Lemke G. Phosphatidylserine is the signal for TAM receptors and their ligands. Trends Biochem Sci. 2017;42(9):738–48.
CAS
PubMed
PubMed Central
Google Scholar
Lemke G, Burstyn-Cohen T. TAM receptors and the clearance of apoptotic cells. Ann N Y Acad Sci. 2010;1209:23–9.
CAS
PubMed
PubMed Central
Google Scholar
Huang M, et al. Structural basis of membrane binding by Gla domains of vitamin K–dependent proteins. Nat Struct Mol Biol. 2003;10(9):751–6.
CAS
Google Scholar
Angelillo-Scherrer A, et al. Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Investig. 2005;115(2):237–46.
CAS
PubMed
PubMed Central
Google Scholar
Law LA, et al. GAS6/TAM pathway signaling in hemostasis and thrombosis. Front Med. 2018;5:137.
Google Scholar
Robert FA, Zwaal PC, Bevers EM. Lipid–protein interactions in blood coagulation. Biochimica et Biophysica Acta (BBA). 1998.
Rezende SM, Simmonds RE, Lane DA. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood. 2004;103(4):1192–201.
CAS
PubMed
Google Scholar
Castoldi E, Hackeng TM. Regulation of coagulation by protein S. Curr Opin Hematol. 2008;15(5):529–36.
CAS
PubMed
Google Scholar
Burstyn-Cohen T, Heeb MJ, Lemke G. Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J Clin Invest. 2009;119(10):2942–53.
CAS
PubMed
PubMed Central
Google Scholar
Tans G, et al. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood. 1991;77(12):2641–8.
CAS
PubMed
Google Scholar
Hong S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712–6.
CAS
PubMed
PubMed Central
Google Scholar
Nonaka S, Nakanishi H. Microglial clearance of focal apoptotic synapses. Neurosci Lett. 2019;707:134317.
CAS
PubMed
Google Scholar
Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 2002;62(21):6132–40.
CAS
PubMed
Google Scholar
Sharma B, Kanwar SS. Phosphatidylserine: a cancer cell targeting biomarker. Semin Cancer Biol. 2018;52(Pt 1):17–25.
CAS
PubMed
Google Scholar
Ran S, Thorpe PE. Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int J Radiat Oncol Biol Phys. 2002;54(5):1479–84.
CAS
PubMed
Google Scholar
Hutterer M, et al. Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clin Cancer Res. 2008;14(1):130–8.
CAS
PubMed
Google Scholar
Sun WS, Fujimoto J, Tamaya T. Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and sky in human uterine endometrial cancers. Ann Oncol. 2003;14(6):898–906.
CAS
PubMed
Google Scholar
Loges S, et al. Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6. Blood. 2010;115(11):2264–73.
CAS
PubMed
Google Scholar
Abboud-Jarrous G, et al. Protein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL. Oncotarget. 2017;8(8):13986–4002.
PubMed
PubMed Central
Google Scholar
Sadahiro H, et al. Activation of the receptor tyrosine kinase AXL regulates the immune microenvironment in glioblastoma. Cancer Res. 2018;78(11):3002–13.
CAS
PubMed
PubMed Central
Google Scholar
Kasikara C, et al. Phosphatidylserine sensing by TAM receptors regulates AKT-dependent Chemoresistance and PD-L1 expression. Mol Cancer Res. 2017;15(6):753–64.
CAS
PubMed
PubMed Central
Google Scholar
Ghosh Roy S. TAM receptors: a phosphatidylserine receptor family and its implications in viral infections. Int Rev Cell Mol Biol. 2020;357:81–122.
PubMed
Google Scholar
Rodriguez-Manzanet R, et al. The costimulatory role of TIM molecules. Immunol Rev. 2009;229(1):259–70.
CAS
PubMed
PubMed Central
Google Scholar
Su EW, Lin JY, Kane LP. TIM-1 and TIM-3 proteins in immune regulation. Cytokine. 2008;44(1):9–13.
CAS
PubMed
PubMed Central
Google Scholar
Meyers JH, et al. TIM-4 is the ligand for TIM-1, and the TIM-1–TIM-4 interaction regulates T cell proliferation. Nat Immunol. 2005;6(5):455–64.
CAS
PubMed
Google Scholar
Khademi M, et al. T cell Ig-and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol. 2004;172(11):7169–76.
CAS
PubMed
Google Scholar
Anderson AC, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science. 2007;318(5853):1141–3.
CAS
PubMed
Google Scholar
Frisancho-Kiss S, et al. Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol. 2006;176(11):6411–5.
CAS
PubMed
Google Scholar
Oikawa T, et al. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease. J Immunol. 2006;177(7):4281–7.
CAS
PubMed
Google Scholar
Kobayashi N, et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity. 2007;27(6):927–40.
CAS
PubMed
PubMed Central
Google Scholar
Zhang X, et al. TIM-4 is expressed on invariant NKT cells but dispensable for their development and function. Oncotarget. 2016;7(44):71099.
PubMed
PubMed Central
Google Scholar
Zhang Q, et al. TIM-4 promotes the growth of non-small-cell lung cancer in a RGD motif-dependent manner. Br J Cancer. 2015;113(10):1484–92.
CAS
PubMed
PubMed Central
Google Scholar
Ruoslahti E. RGD and other recognition sequences for integrins. Annual Rev Cell Dev Biol. 1996;12(1):697–715.
CAS
Google Scholar
Santiago C, et al. Structures of T cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family. Immunity. 2007;26(3):299–310.
CAS
PubMed
PubMed Central
Google Scholar
DeKruyff RH, et al. T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol. 2010;184(4):1918–30.
CAS
PubMed
Google Scholar
Santiago C, et al. Structures of T cell immunoglobulin mucin protein 4 show a metal-ion-dependent ligand binding site where phosphatidylserine binds. Immunity. 2007;27(6):941–51.
CAS
PubMed
PubMed Central
Google Scholar
Miyanishi M, et al. Identification of Tim4 as a phosphatidylserine receptor. Nature. 2007;450(7168):435–9.
CAS
PubMed
Google Scholar
Zhu C, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005;6(12):1245–52.
CAS
PubMed
Google Scholar
Nakae S, et al. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukocyte Biol. 2007;81(5):1258–68.
CAS
PubMed
Google Scholar
Nakayama M, et al. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood. 2009;113(16):3821–30.
CAS
PubMed
Google Scholar
Zhu C, Anderson AC, Kuchroo VK. TIM-3 and its regulatory role in immune responses, in Negative Co-Receptors and Ligands: Springer; 2010. p. 1–15.
Google Scholar
Lee J, et al. Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways. Mol Cell Biol. 2011;31(19):3963–74.
CAS
PubMed
PubMed Central
Google Scholar
Zeidan AM, Komrokji RS, Brunner AM. TIM-3 pathway dysregulation and targeting in cancer. Expert Rev Anticancer Ther. 2021.
Yanagihashi Y, et al. Mouse macrophages show different requirements for phosphatidylserine receptor Tim4 in efferocytosis. Proc Natl Acad Sci U S A. 2017;114(33):8800.
CAS
PubMed
PubMed Central
Google Scholar
Moon B, et al. Mertk interacts with Tim-4 to enhance Tim-4-mediated efferocytosis. Cells. 2020;9(7):1625.
CAS
PubMed Central
Google Scholar
Zakharova L, Svetlova M, Fomina AF. T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor. J Cell Physiol. 2007;212(1):174–81.
CAS
PubMed
Google Scholar
Klibi J, et al. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood. 2009;113(9):1957–66.
CAS
PubMed
Google Scholar
Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9(8):581–93.
PubMed
Google Scholar
Lee H-H, et al. Apoptotic cells activate NKT cells through T cell Ig-like mucin-like–1 resulting in airway hyperreactivity. J Immunol. 2010;185(9):5225–35.
CAS
PubMed
Google Scholar
Ichimura T, et al. Kidney injury molecule–1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Investig. 2008;118(5):1657–68.
CAS
PubMed
PubMed Central
Google Scholar
Rees AJ, Kain R. Kim-1/Tim-1: from biomarker to therapeutic target. Nephrol Dial Transplant. 2008;23(11):3394–6.
CAS
PubMed
Google Scholar
Hazenberg MD, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. Aids. 2003;17(13):1881–8.
PubMed
Google Scholar
Li M, et al. TIM-family proteins inhibit HIV-1 release. Proc Natl Acad Sci. 2014;111(35):E3699–707.
CAS
PubMed
PubMed Central
Google Scholar
Cohen PL, Shao W-H. Gas6/TAM receptors in systemic lupus erythematosus. Dis Markers. 2019;2019.
Pagani S, et al. New insights into the role of Tyro3, Axl, and Mer receptors in rheumatoid arthritis. Dis Markers. 2020;2020.
Finnemann SC, Rodriguez-Boulan E. Macrophage and retinal pigment epithelium phagocytosis: apoptotic cells and photoreceptors compete for αvβ3 and αvβ5 integrins, and protein kinase C regulates αvβ5 binding and cytoskeletal linkage. J Exp Med. 1999;190(6):861–74.
CAS
PubMed
PubMed Central
Google Scholar
Ye H, et al. NMR solution structure of C2 domain of MFG-E8 and insights into its molecular recognition with phosphatidylserine. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2013;1828(3):1083–93.
CAS
Google Scholar
Li H, et al. The Structure and Properties of MFG-E8 and the In vitro Assessment of Its Toxic Effects on Myoblast Cells. Protein Expr Purif. 2020:105720.
Ushikubo M, et al. Milk fat globule epidermal growth factor 8 (MFG-E8) on monocytes is a novel biomarker of disease activity in systemic lupus erythematosus. Lupus. 2021.
Murakami Y, et al. CD300b regulates the phagocytosis of apoptotic cells via phosphatidylserine recognition. Cell Death Differ. 2014;21(11):1746–57.
CAS
PubMed
PubMed Central
Google Scholar
Choi S-C, et al. Cutting edge: mouse CD300f (CMRF-35–like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosis. J Immunol. 2011;187(7):3483–7.
CAS
PubMed
Google Scholar
Dimitrova M, et al. CD300c is uniquely expressed on CD56 bright natural killer cells and differs from CD300a upon ligand recognition. Sci Rep. 2016;6:23942.
CAS
PubMed
PubMed Central
Google Scholar
Vitallé J, et al. CD300 receptor family in viral infections. Eur J Immunol. 2019;49(3):364–74.
PubMed
Google Scholar
Borrego F. The CD300 molecules: an emerging family of regulators of the immune system. Blood. 2013;121(11):1951–60.
CAS
PubMed
PubMed Central
Google Scholar
Das S, et al. Brain angiogenesis inhibitor 1 is expressed by gastric phagocytes during infection with helicobacter pylori and mediates the recognition and engulfment of human apoptotic gastric epithelial cells. FASEB J. 2014;28(5):2214–24.
CAS
PubMed
PubMed Central
Google Scholar
Zhu D, et al. BAI1 suppresses medulloblastoma formation by protecting p53 from Mdm2-mediated degradation. Cancer cell. 2018;33(6):1004–1016. e5.
CAS
PubMed
PubMed Central
Google Scholar
Park SY, et al. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Diff. 2008;15(1):192–201.
CAS
Google Scholar
Park S-Y, et al. Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macrophages. J Cell Sci. 2009;122(18):3365–73.
CAS
PubMed
Google Scholar
Park S-Y, et al. Stabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration. Nat Commun. 2016;7(1):1–15.
Google Scholar
Lee W, et al. Macrophagic Stabilin-1 restored disruption of vascular integrity caused by Sepsis. Thromb Haemost. 2018;118(10):1776–89.
PubMed
Google Scholar
Teissier T, Boulanger É. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging. Biogerontology. 2019;20(3):279–301.
CAS
PubMed
Google Scholar
Liu Z, et al. Activation of RAGE-dependent endoplasmic reticulum stress associates with exacerbated post-myocardial infarction ventricular arrhythmias in diabetes. Am J Physiol-Endocrinol Metab.
Schröter D, Höhn A. Role of advanced glycation end products in carcinogenesis and their therapeutic implications. Curr Pharm Design. 2018;24(44):5245–51.
Google Scholar
Paudel YN, et al. Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s disease (AD): from risk factors to therapeutic targeting. Cells. 2020;9(2):383.
CAS
PubMed Central
Google Scholar
Kerkeni M, Gharbi J. RAGE receptor: may be a potential inflammatory mediator for SARS-COV-2 infection. Med Hypotheses. 2020.
Moriwaki H, et al. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol. 1998;18(10):1541–7.
CAS
PubMed
Google Scholar
Sagar D, et al. LOX-1: a potential driver of cardiovascular risk in SLE patients. PloS ONE. 2020;15(3):e0229184.
CAS
PubMed
PubMed Central
Google Scholar
Murdocca M, et al. LOX-1 and cancer: an indissoluble liaison. Cancer Gene Ther:1–11.
Zwaal RF. Membrane and lipid involvement in blood coagulation. Biochim Biophys Acta. 1978;515(2):163–205.
CAS
PubMed
Google Scholar
Schroit AJ, Zwaal RF. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta. 1991;1071(3):313–29.
CAS
PubMed
Google Scholar
Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood, J Am Soc Hematol. 1997;89(4):1121–32.
CAS
Google Scholar
Bevers EM, Comfurius P, Zwaal RF. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta. 1983;736(1):57–66.
CAS
PubMed
Google Scholar
Kunzelmann K, et al. Molecular functions of anoctamin 6 (TMEM16F): a chloride channel, cation channel, or phospholipid scramblase? Pflügers Archiv-Eur J Physiol. 2014;466(3):407–14.
CAS
Google Scholar
Scudieri P, et al. Ion channel and lipid scramblase activity associated with expression of TMEM16F/ANO6 isoforms. J Physiol. 2015;593(17):3829–48.
CAS
PubMed
PubMed Central
Google Scholar
Le T, et al. An inner activation gate controls TMEM16F phospholipid scrambling. Nat Commun. 2019;10(1):1–13.
Google Scholar
Zwaal RFA, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochimica et Biophysica Acta (BBA)-Mol Cell Biol Lipids. 2004;1636(2–3):119–28.
CAS
Google Scholar
Hussain JF, Mahaut-Smith MP. Reversible and irreversible intracellular Ca2+ spiking in single isolated human platelets. J Physiol. 1999;514(Pt 3):713–8.
CAS
PubMed
PubMed Central
Google Scholar
Takatsu H, et al. Phospholipid flippase ATP11C is endocytosed and downregulated following ca 2+−mediated protein kinase C activation. Nat Commun. 2017;8(1):1–15.
CAS
Google Scholar
McMahon HT, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol. 2011;12(8):517.
CAS
PubMed
Google Scholar
Kelly BT, et al. A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex. Nature. 2008;456(7224):976–9.
CAS
PubMed
PubMed Central
Google Scholar
Pitcher C, et al. Cluster of differentiation antigen 4 (CD4) endocytosis and adaptor complex binding require activation of the CD4 endocytosis signal by serine phosphorylation. Mol Biol Cell. 1999;10(3):677–91.
CAS
PubMed
PubMed Central
Google Scholar
Nelsestuen GL. Role of gamma-carboxyglutamic acid. An unusual protein transition required for the calcium-dependent binding of prothrombin to phospholipid. J Biol Chem. 1976;251(18):5648–56.
CAS
PubMed
Google Scholar
Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 1991;30(43):10363–70.
CAS
PubMed
Google Scholar
Kane WH, Davie EW. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders; 1988.
Google Scholar
Stoilova-McPhie S, et al. Domain organization of membrane-bound factor VIII. Biopolymers Original Res Biomol. 2013;99(7):448–59.
CAS
Google Scholar
Broze GJ Jr. Tissue factor pathway inhibitor and the revised theory of coagulation. Annu Rev Med. 1995;46:103–12.
CAS
PubMed
Google Scholar
van Boven HH, Lane DA. Antithrombin and its inherited deficiency states. Semin Hematol. 1997;34(3):188–204.
PubMed
Google Scholar
Lindahl U, Kjellén L. Heparin or Heparan sulfate-what is the difference. Thromb Haemost. 1991;65(01):044–8.
Google Scholar
Dahlbäck B, Stenflo J. The molecular basis of blood disease; 2000.
Google Scholar
Esmon CT. Molecular events that control the protein C anticoagulant pathway. Thromb Haemost. 1993;69(01):029–35.
Google Scholar
Vermeer C. γ-Carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J. 1990;266(3):625–36.
CAS
PubMed
PubMed Central
Google Scholar
Ohkubo YZ, Tajkhorshid E. Distinct structural and adhesive roles of Ca2+ in membrane binding of blood coagulation factors. Structure. 2008;16(1):72–81.
CAS
PubMed
Google Scholar
Tavoosi N, et al. Molecular determinants of phospholipid synergy in blood clotting. J Biol Chem. 2011;286(26):23247–53.
CAS
PubMed
PubMed Central
Google Scholar
Ortel TL, et al. Deletion analysis of recombinant human factor V. evidence for a phosphatidylserine binding site in the second C-type domain. J Biol Chem. 1992;267(6):4189–98.
CAS
PubMed
Google Scholar
Gilbert GE, Baleja JD. Membrane-binding peptide from the C2 domain of factor VIII forms an amphipathic structure as determined by NMR spectroscopy. Biochemistry. 1995;34(9):3022–31.
CAS
PubMed
Google Scholar
Kalafatis M, Jenny RJ, Mann KG. Identification and characterization of a phospholipid-binding site of bovine factor Va. J Biol Chem. 1990;265(35):21580–9.
CAS
PubMed
Google Scholar
Lecompte MF, Bouix G, Mann KG. Electrostatic and hydrophobic interactions are involved in factor Va binding to membranes containing acidic phospholipids. J Biol Chem. 1994;269(3):1905–10.
CAS
PubMed
Google Scholar
Macedo-Ribeiro S, et al. Crystal structures of the membrane-binding C2 domain of human coagulation factor V. Nature. 1999;402(6760):434–9.
CAS
PubMed
Google Scholar
Pratt KP, et al. Structure of the C2 domain of human factor VIII at 1.5 Å resolution. Nature. 1999;402(6760):439–42.
CAS
PubMed
Google Scholar
Srivastava A, et al. Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor Va. Biochemistry. 2001;40(28):8246–55.
CAS
PubMed
Google Scholar
Majumder R, et al. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa− factor Va complex. Biochemistry. 2005;44(2):711–8.
CAS
PubMed
Google Scholar
Gilbert GE, et al. Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity. Blood, J Am Soc Hematol. 2012;120(9):1923–32.
CAS
Google Scholar
Liu Z, et al. Trp2313-His2315 of factor VIII C2 domain is involved in membrane binding STRUCTURE OF a COMPLEX BETWEEN THE C2 DOMAIN AND AN INHIBITOR OF MEMBRANE BINDING. J Biol Chem. 2010;285(12):8824–9.
CAS
PubMed
PubMed Central
Google Scholar
Dahlbäck B. Human coagluation factor V purification and thrombin-catalyzed activation. J Clin Inv. 1980;66(3):583–91.
Google Scholar
Kalafatis M, Rand MD, Mann KG. Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactor. Biochemistry. 1994;33(2):486–93.
CAS
PubMed
Google Scholar
Reddy EC, Rand ML. Procoagulant phosphatidylserine-exposing platelets in vitro and in vivo. Front Cardiovasc Med. 2020;7.
Nadar S, Lip GYH. The prothrombotic state in hypertension and the effects of antihypertensive treatment. Curr Pharm Design. 2003;9(21):1715–32.
CAS
Google Scholar
Antonarakis SE, Kazazian HH, Tuddenham EGD. Molecular etiology of factor VIII deficiency in hemophilia a. Hum mutat. 1995;5(1):1–22.
CAS
PubMed
Google Scholar
Silachev DN, et al. Effect of MSCs and MSC-Derived Extracellular Vesicles on Human Blood Coagulation. Cells. 2019;8(3).
Wang L, et al. Phosphatidylserine-exposing blood cells and microparticles induce procoagulant activity in non-valvular atrial fibrillation. Int J Cardiol. 2018;258:138–43.
PubMed
Google Scholar
Nakano T, et al. Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. J Biol Chem. 1997;272(47):29411–4.
CAS
PubMed
Google Scholar
Tavoosi N, et al. Factor VII and protein C are phosphatidic acid-binding proteins. Biochemistry. 2013;52(33):5545–52.
CAS
PubMed
Google Scholar
Medfisch SM, et al. Phosphatidylethanolamine-phosphatidylserine binding synergy of seven coagulation factors revealed using Nanodisc arrays on silicon photonic sensors. Sci Rep. 2020;10(1):1–7.
Google Scholar
Novakovic VA, et al. Membrane-binding properties of the factor VIII C2 domain. Biochem J. 2011;435(1):187–96.
CAS
PubMed
Google Scholar
Kim H-Y, Huang BX, Spector AA. Phosphatidylserine in the brain: metabolism and function. Prog Lipid Res. 2014;56:1–18.
CAS
PubMed
Google Scholar
Verdaguer N, et al. Ca2+ bridges the C2 membrane-binding domain of protein kinase Cα directly to phosphatidylserine. EMBO J. 1999;18(22):6329–38.
CAS
PubMed
PubMed Central
Google Scholar
Leventis PA, Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annua Rev Biophysics. 2010;39:407–27.
CAS
Google Scholar
Lemmon MA. Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol. 2008;9(2):99–111.
CAS
PubMed
Google Scholar
Clark GJ, et al. The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol. 2009;30(5):209–17.
CAS
PubMed
Google Scholar
Reutelingsperger CPM, Van Heerde WL, Annexin V. The regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci CMLS. 1997;53(6):527–32.
CAS
PubMed
Google Scholar
Tait JF, Gibson D. Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content. Arc Biochem Biophys. 1992;298(1):187–91.
CAS
Google Scholar
Kay JG, et al. Phosphatidylserine dynamics in cellular membranes. Mol Biol Cell. 2012;23(11):2198–212.
CAS
PubMed
PubMed Central
Google Scholar
Koopman, G., et al., Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. 1994.
Google Scholar
Betal SG, Setty BNY. Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin-binding domain. Transl Res. 2008;152(4):165–77.
Google Scholar
Dashraath P, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J obstet Gynecol. 2020;222(6):521–31.
CAS
PubMed
PubMed Central
Google Scholar
Xu Z, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2.
CAS
PubMed
PubMed Central
Google Scholar
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood, J Am Soc Hematol. 2020;135(23):2033–40.
CAS
Google Scholar
Yang X, et al. Bacterial endotoxin activates the coagulation cascade through gasdermin D-dependent phosphatidylserine exposure. Immunity. 2019;51(6):983–996. e6.
CAS
PubMed
Google Scholar
Tutusaus A, et al. Role of vitamin K-dependent factors protein S and GAS6 and TAM receptors in SARS-CoV-2 infection and COVID-19-associated Immunothrombosis. Cells. 2020;9(10):2186.
CAS
PubMed Central
Google Scholar
Huckriede, J., et al., Markers of NETosis and DAMPs are altered in critically ill COVID-19 patients. 2020.
Google Scholar
Lemke G, Silverman GJ. Blood clots and TAM receptor signalling in COVID-19 pathogenesis. Nat Rev Immunol. 2020:1–2.
Ichimura T, et al. KIM-1/TIM-1 is a Receptor for SARS-CoV-2 in Lung and Kidney. medRxiv. 2020.
Rubin S, et al. Characterisation of acute kidney injury in critically ill patients with severe coronavirus disease-2019 (COVID-19). medRxiv. 2020.
Rothlin CV, et al. TAM receptor signaling in immune homeostasis. Annu Rev Immunol. 2015;33:355–91.
CAS
PubMed
PubMed Central
Google Scholar
Parham P. The immune system. Garland Sci. 2014.
Wang S, et al. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res. 2021:1–15.